Mainz Biomed B.V.

NASDAQ:MYNZ

2.45 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q2
Operating Activities:
Net Income -11.024-5.183-8.252-13.785-12.602-11.428-0.241-0.293-0.293-0.239-0.239
Depreciation & Amortization 0.4970.2040.1710.3170.0620.0350.0350.030.030.0130.013
Deferred Income Tax 0-0.018000-6.487-1.7370000
Stock Based Compensation 1.0280.8192.0964.1425.6826.431.6080000
Change In Working Capital 0.3940.2351.78-0.6840.246-0.7840.0120.0290.0290.1060.106
Accounts Receivables -0.0650.1010.059-0.164-0.0470.057-0.032-0.05-0.050.0850.085
Change In Inventory 0.008-0.158-0.121-0.134-0.038-670.72500000
Change In Accounts Payables 00.485-0.05900670.72500000
Other Working Capital 0.451-0.1931.901-0.3860.332-0.8410.0240.0780.0780.0210.021
Other Non Cash Items 0.96-0.7130.0051.6970.1552.6590.12000.0160.016
Operating Cash Flow -8.145-4.655-5.119-8.313-6.457-3.088-0.229-0.234-0.234-0.104-0.104
Investing Activities:
Investments In Property Plant And Equipment -0.121-0.174-0.124-0.406-0.252-0.012-0.005-0.005-0.00500
Acquisitions Net 000001.2200000
Purchases Of Investments 00000000000
Sales Maturities Of Investments 00000000000
Other Investing Activites -0.3-0.2-0.5001.2200.0050.00500
Investing Cash Flow -0.421-0.374-0.124-0.406-0.2521.208-0.005-0.005-0.00500
Financing Activities:
Debt Repayment 2.036-1.9694.3890-0.04600.2170000
Common Stock Issued 04.50.611002.6060.5030000
Common Stock Repurchased 00000000000
Dividends Paid 00000000000
Other Financing Activities 0.5150.9350-0.14824.13710.39400.0190.019-0.008-0.008
Financing Cash Flow 2.5513.4665.419-0.14824.09210.3940.503-0.019-0.019-0.008-0.008
Other Information:
Effect Of Forex Changes On Cash -0.079-0.798-0.1240.002-0.1030.019-0.0070.2180.21800
Net Change In Cash 0.978-2.2490.053-26.00726.0071.9870.244-0.041-0.041-0.006-0.006
Cash At End Of Period 0.9787.07110.911026.0072.1820.2740.0610.0610.0510.051